Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

A genome-wide association study of severe asthma exacerbations in Latino children and adolescents

Qi Yan, Erick Forno, Esther Herrera-Luis, Maria Pino-Yanes, Cancan Qi, Raimon Rios, Yueh-Ying Han, Soyeon Kim, Sam Oh, Edna Acosta-Pérez, Rong Zhang, Donglei Hu, Celeste Eng, Scott Huntsman, Lydiana Avila, Nadia Boutaoui, Michelle M. Cloutier, Manuel E. Soto-Quiros, Cheng-Jian Xu, Scott T. Weiss, Jessica Lasky-Su, Megan R. Kiedrowski, Camila Figueiredo, Jennifer Bomberger, Mauricio L. Barreto, Glorisa Canino, Wei Chen, Gerard H. Koppelman, Esteban G. Burchard, Juan C. Celedón
European Respiratory Journal 2021 57: 2002693; DOI: 10.1183/13993003.02693-2020
Qi Yan
1Division of Pediatric Pulmonary Medicine, University of Pittsburgh Medical Centre, Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, PA, USA
16Shared first authors
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erick Forno
1Division of Pediatric Pulmonary Medicine, University of Pittsburgh Medical Centre, Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, PA, USA
16Shared first authors
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Erick Forno
Esther Herrera-Luis
2Genomics and Health Group, Dept of Biochemistry, Microbiology, Cell Biology and Genetics, Universidad de La Laguna, La Laguna, Spain
16Shared first authors
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Pino-Yanes
2Genomics and Health Group, Dept of Biochemistry, Microbiology, Cell Biology and Genetics, Universidad de La Laguna, La Laguna, Spain
3CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Maria Pino-Yanes
Cancan Qi
4Dept of Pediatric Pulmonology and Pediatric Allergy, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
5GRIAC Research Institute, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raimon Rios
6Instituto de Ciências da Saúde, Universidade Federal da Bahia, Salvador, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Raimon Rios
Yueh-Ying Han
1Division of Pediatric Pulmonary Medicine, University of Pittsburgh Medical Centre, Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yueh-Ying Han
Soyeon Kim
1Division of Pediatric Pulmonary Medicine, University of Pittsburgh Medical Centre, Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sam Oh
7Dept of Medicine, University of California San Francisco, San Francisco, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edna Acosta-Pérez
8Behavioral Sciences Research Institute, University of Puerto Rico, San Juan, Puerto Rico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rong Zhang
1Division of Pediatric Pulmonary Medicine, University of Pittsburgh Medical Centre, Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Donglei Hu
7Dept of Medicine, University of California San Francisco, San Francisco, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Donglei Hu
Celeste Eng
7Dept of Medicine, University of California San Francisco, San Francisco, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott Huntsman
7Dept of Medicine, University of California San Francisco, San Francisco, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lydiana Avila
9Dept of Pediatrics, Hospital Nacional de Niños, San José, Costa Rica
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nadia Boutaoui
1Division of Pediatric Pulmonary Medicine, University of Pittsburgh Medical Centre, Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michelle M. Cloutier
10Dept of Pediatrics, University of Connecticut, Farmington, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manuel E. Soto-Quiros
9Dept of Pediatrics, Hospital Nacional de Niños, San José, Costa Rica
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cheng-Jian Xu
11CiiM and TWINCORE, joint ventures between the Hannover Medical School and the Helmholtz Centre for Infection Research, Hannover, Germany
12Dept of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Cheng-Jian Xu
Scott T. Weiss
13Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Scott T. Weiss
Jessica Lasky-Su
13Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Megan R. Kiedrowski
14Dept of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Camila Figueiredo
6Instituto de Ciências da Saúde, Universidade Federal da Bahia, Salvador, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer Bomberger
14Dept of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mauricio L. Barreto
15Instituto de Saúde Coletiva, Federal University of Bahia, Salvador, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Glorisa Canino
8Behavioral Sciences Research Institute, University of Puerto Rico, San Juan, Puerto Rico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wei Chen
1Division of Pediatric Pulmonary Medicine, University of Pittsburgh Medical Centre, Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Wei Chen
Gerard H. Koppelman
4Dept of Pediatric Pulmonology and Pediatric Allergy, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
5GRIAC Research Institute, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gerard H. Koppelman
Esteban G. Burchard
7Dept of Medicine, University of California San Francisco, San Francisco, CA, USA
17Shared senior authors
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juan C. Celedón
1Division of Pediatric Pulmonary Medicine, University of Pittsburgh Medical Centre, Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, PA, USA
17Shared senior authors
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: juan.celedon@chp.edu
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Severe asthma exacerbations are a major cause of school absences and healthcare costs in children, particularly those in high-risk racial/ethnic groups.

To identify susceptibility genes for severe asthma exacerbations in Latino children and adolescents, we conducted a meta-analysis of genome-wide association studies (GWAS) in 4010 Latino youth with asthma in four independent cohorts, including 1693 Puerto Ricans, 1019 Costa Ricans, 640 Mexicans, 256 Brazilians and 402 members of other Latino subgroups. We then conducted methylation quantitative trait locus, expression quantitative trait locus and expression quantitative trait methylation analyses to assess whether the top single nucleotide polymorphism (SNP) in the meta-analysis is linked to DNA methylation and gene expression in nasal (airway) epithelium in separate cohorts of Puerto Rican and Dutch children and adolescents.

In the meta-analysis of GWAS, an SNP in FLJ22447 (rs2253681) was significantly associated with 1.55 increased odds of severe asthma exacerbation (95% CI 1.34–1.79, p=6.3×10−9). This SNP was significantly associated with DNA methylation of a CpG site (cg25024579) at the FLJ22447 locus, which was in turn associated with increased expression of KCNJ2-AS1 in nasal airway epithelium from Puerto Rican children and adolescents (β=0.10, p=2.18×10−7).

SNP rs2253681 was significantly associated with both DNA methylation of a cis-CpG in FLJ22447 and severe asthma exacerbations in Latino youth. This may be partly explained by changes in airway epithelial expression of a gene recently implicated in atopic asthma in Puerto Rican children and adolescents (KCNJ2-AS1).

Abstract

A novel SNP in FLJ22447 is significantly associated with both severe asthma exacerbations in Latino youth and DNA methylation of a cis-CpG in nasal epithelium. This CpG is linked to nasal epithelial expression of a gene implicated in atopic asthma. https://bit.ly/33D9Joc

Introduction

Asthma is the most common chronic respiratory disease among children [1]. In the USA, total costs related to asthma exceed $81 billion per year [2]. Severe asthma exacerbations (SAEs), defined as episodes of disease worsening that require a change in treatment to prevent a serious outcome [3], are a major cause of school or work absences and healthcare costs. Of the ∼6.1 million children with asthma in the USA, 2.1% report ≥1 asthma-related hospitalisation and 10.7% report ≥1 asthma-related visit to the emergency department (ED) in the previous year [4]. Despite recent advances, the best predictor of SAEs is having had an SAE in the previous year [5].

Although genome-wide association studies (GWASs) have identified susceptibility loci for asthma [6–8], little is known about genetic determinants of asthma exacerbations, which may be distinct from those for asthma per se. A GWAS in Danish children with asthma (ages 2–6 years) identified cadherin-related family member 3 (CDHR3), a gene not previously associated with asthma, as a susceptibility locus for recurrent SAEs [9]. In a combined GWAS of two cohorts of non-Hispanic white children with asthma, four intronic single nucleotide polymorphisms (SNPs) in cadherin-associated protein alpha 3 (CTNNA3) were significantly associated with SAEs [10], but the association was not replicated in an independent cohort including 786 children and adults with asthma. Moreover, a GWAS of SAEs among 806 non-Hispanic white children and adults with asthma who were being treated with inhaled corticosteroids found no genome-wide significant results [11].

The burden of asthma varies across racial and ethnic groups in the USA and Latin America. For example, Puerto Rican children have a greater prevalence of and morbidity and mortality from asthma than non-Hispanic white children in the USA [12], and Costa Rican adolescents have a greater burden of asthma than those in other Latin American countries [13]. Moreover, recent evidence suggests that some susceptibility variants for asthma-related outcomes are ethnicity-specific [14, 15]. We hypothesised that there would be susceptibility variants for SAEs that would be more common or exert a greater effect in Latino subgroups at risk for morbidity from asthma. To test this hypothesis, we conducted a meta-analysis of GWAS of SAEs among Latino youth with asthma in four independent studies.

Methods

Please refer to the supplementary material for more details.

Study populations included in the meta-analysis of GWAS of severe exacerbations

Hartford-Puerto Rico study

The Hartford-Puerto Rico (HPR) study is a case–control study of childhood asthma in Puerto Ricans [6]. SAEs were defined as ≥1 hospitalisation for asthma or ≥1 ED/urgent care visit for asthma requiring treatment with systemic corticosteroids in the previous year, or ≥1 course of systemic corticosteroids for asthma in the previous year. After quality control (QC) measures, 554 independent children with asthma (236 of whom had ≥1 SAE in the previous year) were included in the genome-wide association analysis, which was conducted using logistic regression under an additive genetic model, adjusting for age, sex, inhaled steroid use and the first two principal components (PCs), calculated using smartPCA [16].

The Genetics of Asthma in Latino Americans study

The Genetics of Asthma in Latino Americans (GALA II) study is a case­–control study of asthma in Latino children and youth [17]. An SAE was defined as having had ≥1 of the following events in the previous year: hospitalisations for asthma, ED visits or unscheduled and urgent doctor's visits because of asthma, or treatment with systemic corticosteroids for asthma. The current analysis focused on 2181 children with asthma (1283 of whom had ≥1 SAE) and self-reported Latino ethnicity (1139 Puerto Rican, 640 Mexican and 402 from other groups). Association testing was conducted using logistic regression under an additive genetic model, adjusting for age, sex, inhaled steroid use, ethnicity and the first two PCs.

The Genetics of Asthma in Costa Rica Study

The Genetics of Asthma in Costa Rica Study (GACRS) is a genetic study of nuclear families of children with asthma in Costa Rica [18, 19]. An SAE was defined as ≥1 ED visit for asthma or ≥1 hospitalisation for asthma in the previous year. After QC, 1019 independent children with asthma (851 with ≥1 SAE) were included in the analysis, which was also conducted using logistic regression under an additive genetic model, adjusting for age, sex, inhaled steroid use and the first two PCs.

The Social Changes, Asthma and Allergy in Latin America study, Bahia, Brazil

The Social Changes, Asthma and Allergy in Latin America (SCAALA) study is a longitudinal study of asthma and allergic diseases of Brazilian children [20]. Children who reported asthma symptoms and had data on SAEs (n=256) were included in this analysis. An SAE was defined as ≥1 ED visit or ≥1 hospitalisation due to wheeze in the previous year. The analysis was conducted using logistic regression under an additive genetic model, with adjustment for age, sex and the first two PCs from genotypic data.

Study populations included in molecular quantitative trait analyses in nasal epithelium

The Epigenetic Variation and Childhood Asthma in Puerto Rico study

Nasal (airway) epithelium can serve as a surrogate marker for DNA methylation and gene expression in bronchial (airway) epithelium [21]. In the Epigenetic Variation and Childhood Asthma in Puerto Rico (EVA-PR) study, whole-genome methylation assays were performed using HumanMethylation450 BeadChips (Illumina, San Diego, CA, USA). After QC, 227 901 CpG probes remained for the analysis of nasal epithelium, and M-values were used in all downstream analyses. RNA sequencing was performed with the Illumina NextSeq 500 platform, with paired-end reads at 75 cycles and 80 million reads per sample. After QC, 16 737 genes were retained for the analysis. The R function sva was used to estimate latent factors that capture unknown data heterogeneity [22]. Of the 543 study participants, 457 had complete genome-wide data for genotypes, methylation and transcriptomics in nasal epithelium (supplementary figure S1).

Prevention and Incidence of Asthma and Mite Allergy study

The Prevention and Incidence of Asthma and Mite Allergy (PIAMA) study is a birth cohort study of children born in the Netherlands in 1996 and 1997 [23, 24]. A total of 479 nasal epithelial samples were hybridised to the Infinium HumanMethylation450 BeadChip arrays. After QC, 455 samples and 436 824 probes remained, and 432 samples had matched genotype data. RNA sequencing was performed with the Illumina HiSeq 2500 platform with paired-end sequencing. After stringent QC, 17 156 genes and 326 samples remained, with 233 samples having matched genotype data [25].

Meta-analysis of GWAS of SAEs

METAL [26] software was used to perform the meta-analysis of GWAS of SAEs, using data from HPR, GALA II, GACRS and SCAALA.

Molecular quantitative trait locus analyses

To estimate the effects of our top SNP on DNA methylation and gene expression, we conducted a methylation quantitative trait locus (mQTL) analysis to test for an association between our top SNP and genome-wide DNA methylation in nasal epithelium, and an expression quantitative trait locus (eQTL) analysis to test for an association between our top SNP and genome-wide gene expression in nasal epithelium. We then conducted an expression quantitative trait methylation (eQTM) analysis to test whether the top CpG site identified in the mQTL analysis was associated with genome-wide gene expression in nasal epithelium. All analyses were adjusted for age, sex, asthma status, atopy status, the top five PCs from genotypic data and latent factors estimated from sva [22]. In addition, RNA sequencing batch and RNA sample sorting protocol (i.e. whole cells or CD326-positive nasal epithelial cells) [21] were adjusted for in the eQTM analyses, and methylation batch was adjusted for in the mQTL and eQTM analyses; both cis and trans effects were considered.

Pathway analysis

A pathway analysis was performed with MAGMA [27], which conducts SNP-wise gene analysis of summary statistics with correction for linkage disequilibrium between variants and genes, to test whether sets of genes are jointly associated with a phenotype (i.e. asthma exacerbation) compared to other genes across the genome. Adaptive permutation was used to produce an empirical p-value and false discovery rate (FDR). Gene sets used in the analyses were from Gene Ontology (GO) [28, 29], Kyoto Encyclopedia of Genes and Genomes (KEGG) [30, 31], Reactome [32, 33] and BioCarta pathways.

Results

The characteristics of the 4010 participants in the four studies included in the meta-analysis of GWAS of SAEs are shown in table 1. In total, there were 2509 children with asthma and ≥1 SAE (cases) and 1501 children with asthma but no SAEs (controls). Compared to subjects who participated in the HPR or SCAALA studies, those in GALA II were older and those in GACRS were younger. Compared to subjects in the other studies, those in GACRS were more likely to be male and to have had ≥1 severe asthma exacerbation in the previous year.

View this table:
  • View inline
  • View popup
TABLE 1

Summary of main characteristics of study participants

Approximately six million genotyped and imputed SNPs with a minor allele frequency (MAF) ≥0.05 were included in the meta-analysis of GWAS of SAEs. In this meta-analysis, one SNP (rs2253681, in FLJ22447 on chromosome 14q23.2) was significantly associated with SAEs (p<5×10−8) (figure 1a). This SNP was genotyped in HPR, GALA II and SCAALA, and imputed in GACRS with imputation quality r2=0.96. Each copy of the minor allele (A) of SNP rs2253681 was associated with 1.55 times increased odds of SAEs (95% CI 1.34–1.79, p=6.3×10−9, figure 1b). The Q-Q plot (figure 1c) showed no inflation for the results for each of the four individual cohorts or for the pooled analysis (figure 2). There was no significant interaction between SNP rs2253681 and inhaled steroid use on SAEs in the GWAS conducted in the HPR, GALA II or GACRS cohorts (p for interaction≥0.15 in all instances).

FIGURE 1
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1

a) Manhattan plot showing the summary meta-analysis results of Hartford-Puerto Rico (HPR), Genetics of Asthma in Latino Americans II (GALA II), Genetics of Asthma in Costa Rica Study (GACRS) and Social Changes, Asthma and Allergy in Latin America (SCAALA) studies. The chromosomal position of each single nucleotide polymorphism (SNP) is displayed along the x-axis and the negative logarithm of the association p-value is displayed on the y-axis. The blue line represents the suggestive significance line (p<1×10−6). The red line represents the genome-wide significance line (p<5×10−8). b) Results of the meta-analysis on the chromosome 14 region. The relative location of genes and the direction of transcription are shown in the lower portion of the figure, and the chromosomal position is shown on the x-axis. The vertical blue line shows the recombination rate across the region (right y-axis), and the left y-axis shows the significance of the associations. The purple diamond shows the p-value for rs2253681, which is the most significant SNP in the meta-analysis. The circles show the p-values for all other SNPs and are colour-coded according to the level of linkage disequilibrium with rs2253681 in the 1000 Genome Project Admixed American (AMR) population. This plot was generated at www.locuszoom.org/. c) QQ plots for the meta-analysis. λ is the genomic control value.

FIGURE 2
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2

Forest plots of odds ratio and 95% CI for the association with asthma for rs2253681, the most significant single nucleotide polymorphism in the meta-analysis. The heterogeneity measure I2=0 implies no heterogeneity among the odds ratios from the four studies (see supplementary material for details). HPR: Hartford-Puerto Rico cohort; GACRS: Genetics of Asthma in Costa Rica Study; GALA II: Genetics of Asthma in Latino Americans II; SCAALA: Social Changes, Asthma and Allergy in Latin America; MAF: minor allele frequency.

We then examined whether SNPs previously associated with asthma in either a multi-ancestry meta-analysis [7] or a meta-analysis from the UK Biobank [34] were associated with SAEs in our analysis (supplementary table S1). None of the previously reported asthma-susceptibility SNPs was significantly associated with SAEs in our meta-analysis of Latino youth. Moreover, no SNPs associated with SAEs or asthma hospitalisations in previous candidate-gene studies (e.g. IL13, IL4RA) or GWAS (e.g. CDHR3, CTNNA3) [9, 10, 18, 35–38] were significantly associated with SAEs in our meta-analysis (meta-p≥0.05 in all instances, supplementary table S2). Although the previously reported SNP rs7216389 in ORMDL3 on chromosome 17q21 was nominally associated with SAEs in HPR (p=1.6×10−3), it did not reach statistical significance in our meta-analysis (meta-p=0.06, supplementary table S2).

To examine whether SNP rs2253681 affects methylation of the FLJ22447 locus in nasal epithelium, we first conducted an mQTL analysis. In this analysis, rs2253681 was a significant cis-acting mQTL in nasal epithelium for cg25024579 in FLJ22447 (β=0.55, p=3.6×10−16 and FDR-p=8.1×10−11 in EVA-PR; β=0.34, p=1.2×10−11 in PIAMA; and meta-p=9.5×10−25 for a combined analysis of EVA-PR and PIAMA; table 2). In addition, among the top 20 mQTL, cg05223396 in SH3PXD2B, cg13127574 in ADSSL1 and cg21115391 in CCDC67 were associated with rs2253681 at p<0.05 in PIAMA, in the same direction as in EVA-PR (table 2). Next, we conducted an eQTL analysis of SNP rs2253681 in the FLJ22447 locus and gene expression in nasal epithelium, and found no cis or trans genome-wide significant results (supplementary table S3). Among the top 20 eQTL, SRF was associated with rs2253681 at p<0.05 in PIAMA, in the same direction as in EVA-PR (supplementary table S3).

View this table:
  • View inline
  • View popup
TABLE 2

Top 20 methylation quantitative trait locus for rs2253681 in EVA-PR nasal epithelial cells and replication results from PIAMA

Given the association between SNP rs2253681 and methylation of cg25024579, we then examined the effect of that CpG on gene expression in nasal epithelium by conducting an eQTM analysis (table 3). In this analysis, methylation of cg25024579 was significantly associated in trans with expression of KCNJ2 antisense RNA 1 (KCNJ2-AS1) on chromosome 17q24.3 (β=0.10, p=2.2×10−7 and FDR-p=3.2×10−3) in EVA-PR. Although this was not replicated in PIAMA, the observed association remained significant in the combined analysis of the two cohorts (β=0.09, p=1.4×10−6). The top cis-eQTM gene in the current analysis in EVA-PR was protein kinase C-η (PKCη), encoded by PRKCH (β=0.07, p=4.1×10−5 and FDR-p=1.5×10−1). PRKCH expression was also associated with cg2504579 methylation in PIAMA, in the same direction of association as in EVA-PR (β=0.11, p=1.4×10−2; and p=2.4×10−6 in the combined analysis of EVA-PR and PIAMA). Among the top 20 eQTM in EVA-PR, SLC27A2 expression was associated with cg25024579 methylation in PIAMA, in the same direction of association as in EVA-PR (β=0.22, p=4.2×10−5 in PIAMA; and β=0.09, p=4.9×10−7 in the combined analysis of the two cohorts). In addition, expression of FOCAD, PIGF and ERLEC1 was associated with cg25024579 methylation in PIAMA at p<0.05, in the same direction as in EVA-PR.

View this table:
  • View inline
  • View popup
TABLE 3

Top 20 expression quantitative trait methylations for cg25024579 in EVA-PR nasal epithelial cells and replication results from PIAMA

To further assess the biological relevance of the FLJ22447 locus, we conducted an SNP-wise pathway analysis of SAEs using the meta-analysis results and evaluated public repositories and databases. Although there were no pathways associated with SAEs after adjusting for multiple testing, there were a number of nominally significant pathways that included genes on chromosome 14q23.2, near FLJ22447 (supplementary table S4).

In a sensitivity analysis, we repeated the GWAS of SAEs after imputing genotypes using the 1000 Genomes Ad Mixed American (AMR) reference panel instead of the Haplotype Reference Consortium (HRC) r1.1 2016 reference panel (supplementary material), obtaining very similar results (supplementary figure S2 and supplementary table S5).

Discussion

Our combined analysis including 4010 youths in four study cohorts showed that a novel SNP in FLJ22447 (rs2253681) is significantly associated with SAEs (p=6.3×10−9) among children and adolescents in Latino subgroups affected with asthma (Puerto Ricans, Costa Ricans, Mexicans and Brazilians) [12]. In an mQTL analysis in nasal epithelium, this SNP was significantly associated with DNA methylation of a CpG site at the FLJ22447 locus (cg25024579), which was in turn significantly associated with the expression of KCNJ2-AS1 in nasal epithelium.

FLJ22447 codes for a long non-coding RNA, a type of RNA that does not get translated to a protein but may serve pre- and post-transcriptional regulatory functions. FLJ22447 partially overlaps with AL355916.3, which encodes a protein kinase C paralog expressed in epithelial tissues. Of note, an SNP in AL355916.3 has been associated with forced expiratory volume in 1 s/forced vital capacity and bronchodilator response in adults [34]. FLJ22447 mediates interleukin (IL)-33 upregulation in activated fibroblasts; together, FLI22447 and IL-33 can increase fibroblast expression of α-smooth muscle actin (α-SMA), vimentin and N-cadherin [35], which are associated with myofibroblast differentiation and airway remodelling [36, 37].

KCNJ2-AS1 also encodes a long non-coding RNA. Expression of KCNJ2-AS1 (log2(fold-change)=0.34, p=3.9×10−6, FDR-p=3.1×10−5) was significantly associated with atopic asthma in our recent transcriptome-wide association study of atopic asthma in Puerto Rican children and adolescents [38]. SNPs rs8066985 and rs312750 near KCNJ2-AS1 are associated with body mass index and waist-to-hip ratio [39, 40], which are associated with worse asthma outcomes in children and adults. To our knowledge, this is the first study linking FLJ22447 or KCNJ2-AS1 to SAEs in children and adolescents.

While not significant genome wide, the top cis-eQTM gene in EVA-PR was PRKCH, which is adjacent to FLJ22447 and most highly expressed in the lungs [41]. Both methylation and transcription of this gene in nasal (airway) epithelium were recently associated with atopic asthma in Puerto Rican children and adolescents [21]. PKCη, encoded by PRKCH, plays a key role in the assembly and maintenance of epithelial tight junctions. PKCη phosphorylates occludin on threonine residues (T403 and T404), and such phosphorylation is required for the assembly and/or maintenance of occludin in epithelial tight junctions that are key to the integrity and function of the airway epithelial barrier [42].

Recent GWAS of exacerbations in non-Hispanic white children identified SNPs in two genes, CDHR3 and CTNNA3 [9, 10], neither of which replicated in our analysis, despite our having similar or larger sample sizes than those in the original studies. Similarly, a previously reported association between an SNP on chromosome 17q21 (rs7216389) and SAEs was not statistically significant in our meta-analysis (p=0.06). While an association between the 17q21 locus and asthma is widely recognised, whether this locus is linked to severe disease exacerbations among children with asthma is less clear. The initial report in paediatric asthma analysed a cohort of 376 children and reported 80 with recurrent wheezing and 66 with asthma [43]. The authors then analysed the rate of severe exacerbations within the full cohort (57 among the 376 participants), rather than comparing children with asthma and an exacerbation to those with asthma but no exacerbation. A recent meta-analysis reported a significant association between rs7216389 and asthma hospitalisations and ED visits in children, but, while the pooled estimates were significant, only four of the 13 cohorts showed significant results [44]. Although the lack of an association between CDHR3 and SAEs in the current study may be due to differences in the age of participants and outcome definitions across studies, our results for FLJ22447 are novel and further highlight the importance of studying asthma outcomes in children and adolescents of diverse races and ethnicities.

We recognise several study limitations. First, we lack data on viral infections or air pollution, which may interact with genetic or epigenetic mechanisms causing SAEs in children. Second, we cannot assess temporal relationships between DNA methylation or gene expression and SAEs in our cross-sectional analysis. Third, we had insufficient statistical power to detect either uncommon risk alleles or alleles with modest genetic effects on SAEs. Moreover, we had limited statistical power to detect an interaction between our top SNP and inhaled steroid use on SAEs or for our molecular quantitative trait analyses, and lacked a replication cohort for analyses of DNA methylation or gene expression in nasal epithelium and SAEs (because PIAMA lacks adequate data on asthma exacerbations). Fourth, the definitions of SAEs varied across the study cohorts. However, we obtained similar results in a sensitivity analysis for the HPR and GALA II cohorts, in which we re-ran the GWAS after excluding subjects who received systemic corticosteroids but did not report an unscheduled and acute visit for asthma (data not shown).

In summary, we have identified a novel SNP in FLJ22447 that is significantly associated with both SAEs in Latino children and adolescents and DNA methylation of a cis-CpG in FLJ22447 in nasal epithelium. This CpG is, in turn, linked to nasal epithelial expression of a gene recently implicated in atopic asthma in children and adolescents (KCNJ2-AS1). Future longitudinal studies of asthma-omics should assess whether and how genetic variants affect airway epithelial function and SAEs in childhood.

Supplementary material

Supplementary Material

Please note: supplementary material is not edited by the Editorial Office, and is uploaded as it has been supplied by the author.

Supplementary material ERJ-02693-2020.SUPPLEMENT

Shareable PDF

Supplementary Material

This one-page PDF can be shared freely online.

Shareable PDF ERJ-02693-2020.Shareable

Footnotes

  • This article has supplementary material available from erj.ersjournals.com

  • Author contributions: Q. Yan, E. Forno and J.C. Celedón conceived and designed the study. E.G. Burchard, G.H. Koppelman and J.C. Celedón obtained funding. Q. Yan, E. Herrera-Luis, M. Pino-Yanes and R. Rios conducted the primary analysis and interpreted data. C. Qi, Y-Y. Han, S. Kim, S. Oh, E. Acosta-Pérez, R. Zhang, D. Hu, C. Eng, S. Huntsman, L. Avila, N. Boutaoui, M.M. Cloutier, M.E. Soto-Quiros, C-J. Xu, S.T. Weiss, J. Lasky-Su, M.R. Kiedrowski, C. Figueiredo, J. Bomberger, M.L. Barreto, G. Canino, W. Chen and E.G. Burchard participated in data collection and data analysis. Q. Yan, E. Forno and J.C. Celedón prepared the first draft of the manuscript. All authors reviewed the draft for intellectual content, and approved submission of the final version of the manuscript.

  • Support statement: This work was supported by grants HL079966, HL117191 and MD011764 from the US National Institutes of Health (NIH) to J.C. Celedón. Q. Yan's contribution was supported by grant HL138098 from the US NIH. E. Forno's contribution was supported by grant HL149693 from the US NIH. The GALA II study was supported by US NIH grants to E.G. Burchard: HL088133, HL004464, HL117004, ES015794, ES24844, TRDRP 24RT 0025, MD006902 and GM007546. M. Pino-Yanes was supported by the Ramón y Cajal Program (RYC-2015-17205) and by grant SAF2017-83417R from the Spanish Ministry of Economy, Industry and Competitiveness. The PIAMA study was supported by The Netherlands Organisation for Health Research and Development; The Netherlands Organisation for Scientific Research; the Lung Foundation of the Netherlands (with methylation and gene expression studies supported by AF 4.1.14.001); The Netherlands Ministry of Spatial Planning, Housing and the Environment; and The Netherlands Ministry of Health, Welfare and Sport. C. Qi was supported by a grant from the China Scholarship Council. Funding information for this article has been deposited with the Crossref Funder Registry.

  • Conflict of interest: Q. Yan reports grants from National Institutes of Health (K01HL138098), during the conduct of the study.

  • Conflict of interest: E. Forno has nothing to disclose.

  • Conflict of interest: E. Herrera-Luis reports grants from the Spanish Ministry of Science, Innovation and Universities (PRE2018-083837), during the conduct of the study.

  • Conflict of interest: M. Pino-Yanes reports grants from Spanish Ministry of Economy, Industry and Competitiveness, the State Research Agency and the European Regional Development Funds from the European Union (MINECO/AEI/FEDER, UE, SAF2017-83417R), and grants from Spanish Ministry of Economy, Industry and Competitiveness (Ramón y Cajal grant RYC-2015-17205), during the conduct of the study.

  • Conflict of interest: C. Qi has nothing to disclose.

  • Conflict of interest: R. Rios has nothing to disclose.

  • Conflict of interest: Y-Y. Han has nothing to disclose.

  • Conflict of interest: S. Kim has nothing to disclose.

  • Conflict of interest: S. Oh has nothing to disclose.

  • Conflict of interest: E. Acosta-Pérez has nothing to disclose.

  • Conflict of interest: R. Zhang has nothing to disclose.

  • Conflict of interest: D. Hu has nothing to disclose.

  • Conflict of interest: C. Eng has nothing to disclose.

  • Conflict of interest: S. Huntsman has nothing to disclose.

  • Conflict of interest: L. Avila has nothing to disclose.

  • Conflict of interest: N. Boutaoui has nothing to disclose.

  • Conflict of interest: M.M. Cloutier has nothing to disclose.

  • Conflict of interest: M.E. Soto-Quiros has nothing to disclose.

  • Conflict of interest: C-J. Xu has nothing to disclose.

  • Conflict of interest: S.T. Weiss has nothing to disclose.

  • Conflict of interest: J. Lasky-Su has nothing to disclose.

  • Conflict of interest: M.R. Kiedrowski has nothing to disclose.

  • Conflict of interest: C. Figueiredo has nothing to disclose.

  • Conflict of interest: J. Bomberger has nothing to disclose.

  • Conflict of interest: M.L. Barreto has nothing to disclose.

  • Conflict of interest: G. Canino has nothing to disclose.

  • Conflict of interest: W. Chen has nothing to disclose.

  • Conflict of interest: G.H. Koppelman reports grants from the Lung Foundation of the Netherlands, during the conduct of the study; grants from Ubbo Emmius Foundation, TETRI Foundation, GSK, Vertex, TEVA, the Lung Foundation of the Netherlands and the European Union H2020 Program, outside the submitted work; and has served on advisory boards to GSK and PURE IMS (fees paid to institution).

  • Conflict of interest: E.G. Burchard reports grants from National Heart, Lung, and Blood Institute, National Institute of Health, General Medical Sciences, National Institute on Minority Health and Health Disparities, Tobacco-Related Disease Research Program, Food and Drug Administration, and the Sandler Family Foundation, during the conduct of the study.

  • Conflict of interest: J.C. Celedón has received research materials from GSK and Merck (inhaled steroids) and Pharmavite (vitamin D and placebo capsules), in order to provide medications free of cost to participants in NIH-funded studies, unrelated to the current work.

  • Received July 15, 2020.
  • Accepted September 30, 2020.
  • Copyright ©ERS 2021
https://www.ersjournals.com/user-licence

References

  1. ↵
    1. Center for Disease Control and Prevention
    . Asthma. Data, statistics and surveillance. www.cdc.gov/asthma/most_recent_data.htm. Date last accessed: September 18, 2020.
  2. ↵
    1. Nurmagambetov T,
    2. Kuwahara R,
    3. Garbe P
    . The economic burden of asthma in the United States, 2008–2013. Ann Am Thorac Soc 2018; 15: 348–356. doi:10.1513/AnnalsATS.201703-259OC
    OpenUrlCrossRefPubMed
  3. ↵
    1. Fuhlbrigge A,
    2. Peden D,
    3. Apter AJ, et al.
    Asthma outcomes: exacerbations. J Allergy Clin Immunol 2012; 129: Suppl. 3, S34–S48. doi:10.1016/j.jaci.2011.12.983
    OpenUrlCrossRefPubMed
  4. ↵
    1. Akinbami LJ,
    2. Moorman JE,
    3. Liu X
    . Asthma prevalence, health care use, and mortality: United States, 2005–2009. Natl Health Stat Report 2011; 32: 1–14.
    OpenUrl
  5. ↵
    1. Puranik S,
    2. Forno E,
    3. Bush A, et al.
    Predicting severe asthma exacerbations in children. Am J Respir Crit Care Med 2017; 195: 854–859. doi:10.1164/rccm.201606-1213PP
    OpenUrlPubMed
  6. ↵
    1. Yan Q,
    2. Brehm J,
    3. Pino-Yanes M, et al.
    A meta-analysis of genome-wide association studies of asthma in Puerto Ricans. Eur Respir J 2017; 49: 1601505. doi:10.1183/13993003.01505-2016
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Demenais F,
    2. Margaritte-Jeannin P,
    3. Barnes KC, et al.
    Multiancestry association study identifies new asthma risk loci that colocalize with immune-cell enhancer marks. Nat Genet 2018; 50: 42–53. doi:10.1038/s41588-017-0014-7
    OpenUrl
  8. ↵
    1. Torgerson DG,
    2. Ampleford EJ,
    3. Chiu GY, et al.
    Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations. Nat Genet 2011; 43: 887–892. doi:10.1038/ng.888
    OpenUrlCrossRefPubMed
  9. ↵
    1. Bonnelykke K,
    2. Sleiman P,
    3. Nielsen K, et al.
    A genome-wide association study identifies CDHR3 as a susceptibility locus for early childhood asthma with severe exacerbations. Nat Genet 2014; 46: 51–55. doi:10.1038/ng.2830
    OpenUrlCrossRefPubMed
  10. ↵
    1. McGeachie MJ,
    2. Wu AC,
    3. Tse SM, et al.
    CTNNA3 and SEMA3D: promising loci for asthma exacerbation identified through multiple genome-wide association studies. J Allergy Clin Immunol 2015; 136: 1503–1510. doi:10.1016/j.jaci.2015.04.039
    OpenUrlCrossRef
  11. ↵
    1. Dahlin A,
    2. Denny J,
    3. Roden DM, et al.
    CMTR1 is associated with increased asthma exacerbations in patients taking inhaled corticosteroids. Immun Inflamm Dis 2015; 3: 350–359. doi:10.1002/iid3.73
    OpenUrlCrossRef
  12. ↵
    1. Rosser FJ,
    2. Forno E,
    3. Cooper PJ, et al.
    Asthma in Hispanics. An 8-year update. Am J Respir Crit Care Med 2014; 189: 1316–1327. doi:10.1164/rccm.201401-0186PP
    OpenUrlCrossRefPubMed
  13. ↵
    1. Forno E,
    2. Gogna M,
    3. Cepeda A, et al.
    Asthma in Latin America. Thorax 2015; 70: 898–905. doi:10.1136/thoraxjnl-2015-207199
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Burkart KM,
    2. Sofer T,
    3. London SJ, et al.
    A Genome-wide association study in Hispanics/latinos identifies novel signals for lung function. The Hispanic Community Health Study/Study of Latinos. Am J Respir Crit Care Med 2018; 198: 208–219. doi:10.1164/rccm.201707-1493OC
    OpenUrl
  15. ↵
    1. Mak ACY,
    2. White MJ,
    3. Eckalbar WL, et al.
    Whole-genome sequencing of pharmacogenetic drug response in racially diverse children with asthma. Am J Respir Crit Care Med 2018; 197: 1552–1564. doi:10.1164/rccm.201712-2529OC
    OpenUrlCrossRefPubMed
  16. ↵
    1. Price AL,
    2. Patterson NJ,
    3. Plenge RM, et al.
    Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006; 38: 904–909. doi:10.1038/ng1847
    OpenUrlCrossRefPubMedWeb of Science
  17. ↵
    1. Nishimura KK,
    2. Galanter JM,
    3. Roth LA, et al.
    Early-life air pollution and asthma risk in minority children. The GALA II and SAGE II studies. Am J Respir Crit Care Med 2013; 188: 309–318. doi:10.1164/rccm.201302-0264OC
    OpenUrlCrossRefPubMedWeb of Science
  18. ↵
    1. Hunninghake GM,
    2. Soto-Quiros ME,
    3. Avila L, et al.
    Polymorphisms in IL13, total IgE, eosinophilia, and asthma exacerbations in childhood. J Allergy Clin Immunol 2007; 120: 84–90. doi:10.1016/j.jaci.2007.04.032
    OpenUrlCrossRefPubMedWeb of Science
  19. ↵
    1. Hunninghake GM,
    2. Soto-Quiros ME,
    3. Avila L, et al.
    Sensitization to Ascaris lumbricoides and severity of childhood asthma in Costa Rica. J Allergy Clin Immunol 2007; 119: 654–661. doi:10.1016/j.jaci.2006.12.609
    OpenUrlCrossRefPubMedWeb of Science
  20. ↵
    1. Barreto ML,
    2. Cunha SS,
    3. Alcantara-Neves N, et al.
    Risk factors and immunological pathways for asthma and other allergic diseases in children: background and methodology of a longitudinal study in a large urban center in Northeastern Brazil (Salvador-SCAALA study). BMC Pulm Med 2006; 6: 15. doi:10.1186/1471-2466-6-15
    OpenUrlCrossRefPubMed
  21. ↵
    1. Forno E,
    2. Wang T,
    3. Qi C, et al.
    DNA methylation in nasal epithelium, atopy, and atopic asthma in children: a genome-wide study. Lancet Respir Med 2019; 7: 336–346. doi:10.1016/S2213-2600(18)30466-1
    OpenUrl
  22. ↵
    1. Leek JT,
    2. Johnson WE,
    3. Parker HS, et al.
    The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics 2012; 28: 882–883. doi:10.1093/bioinformatics/bts034
    OpenUrlCrossRefPubMedWeb of Science
  23. ↵
    1. Brunekreef B,
    2. Smit J,
    3. de Jongste J, et al.
    The prevention and incidence of asthma and mite allergy (PIAMA) birth cohort study: design and first results. Pediatr Allergy Immunol 2002; 13: 55–60. doi:10.1034/j.1399-3038.13.s.15.1.x
    OpenUrlCrossRefPubMedWeb of Science
  24. ↵
    1. Wijga A,
    2. Smit HA,
    3. Brunekreef B, et al.
    Are children at high familial risk of developing allergy born into a low risk environment? The PIAMA Birth Cohort Study. Clin Exp Allergy 2001; 31: 576–581. doi:10.1046/j.1365-2222.2001.01072.x
    OpenUrlCrossRefPubMedWeb of Science
  25. ↵
    1. Qi C,
    2. Jiang Y,
    3. Yang IV, et al.
    Nasal DNA methylation profiling of asthma and rhinitis. J Allergy Clin Immunol 2020; 145: 1655–1663. doi:10.1016/j.jaci.2019.12.911
    OpenUrl
  26. ↵
    1. Willer CJ,
    2. Li Y,
    3. Abecasis GR
    . METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 2010; 26: 2190–2191. doi:10.1093/bioinformatics/btq340
    OpenUrlCrossRefPubMedWeb of Science
  27. ↵
    1. de Leeuw CA,
    2. Mooij JM,
    3. Heskes T, et al.
    MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput Biol 2015; 11: e1004219. doi:10.1371/journal.pcbi.1004219
    OpenUrlCrossRefPubMed
  28. ↵
    1. Ashburner M,
    2. Ball CA,
    3. Blake JA, et al.
    Gene ontology: tool for the unification of biology. Nat Genet 2000; 25: 25–29. doi:10.1038/75556
    OpenUrlCrossRefPubMedWeb of Science
  29. ↵
    1. Gene Ontology Consortium
    . Gene Ontology Consortium: going forward. Nucleic Acids Res 2015; 43: D1049–D1056. doi:10.1093/nar/gku1179
    OpenUrlCrossRefPubMed
  30. ↵
    1. Kanehisa M,
    2. Sato Y,
    3. Kawashima M, et al.
    KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res 2016; 44: D457–D462. doi:10.1093/nar/gkv1070
    OpenUrlCrossRefPubMed
  31. ↵
    1. Ogata H,
    2. Goto S,
    3. Sato K, et al.
    KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res 1999; 27: 29–34. doi:10.1093/nar/27.1.29
    OpenUrlCrossRefPubMedWeb of Science
  32. ↵
    1. Fabregat A,
    2. Sidiropoulos K,
    3. Garapati P, et al.
    The Reactome pathway knowledgebase. Nucleic Acids Res 2016; 44: D481–D487. doi:10.1093/nar/gkv1351
    OpenUrlCrossRefPubMed
  33. ↵
    1. Croft D,
    2. O'Kelly G,
    3. Wu G, et al.
    Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res 2011; 39: D691–D697. doi:10.1093/nar/gkq1018
    OpenUrlCrossRefPubMedWeb of Science
  34. ↵
    1. Zhu Z,
    2. Lee PH,
    3. Chaffin MD, et al.
    A genome-wide cross-trait analysis from UK Biobank highlights the shared genetic architecture of asthma and allergic diseases. Nat Genet 2018; 50: 857–864.35. doi:10.1038/s41588-018-0121-0
    OpenUrl
  35. ↵
    1. Ding L,
    2. Ren J,
    3. Zhang D, et al.
    A novel stromal lncRNA signature reprograms fibroblasts to promote the growth of oral squamous cell carcinoma via LncRNA-CAF/interleukin-33. Carcinogenesis 2018; 39: 397–406. doi:10.1093/carcin/bgy006
    OpenUrl
  36. ↵
    1. Hackett T-L,
    2. Warner S,
    3. Stefanowicz D, et al.
    Induction of epithelial-mesenchymal transition in primary airway epithelial cells from patients with asthma by transforming growth factor-β1. Am J Respir Crit Care Med 2009; 180: 122–133. doi:10.1164/rccm.200811-1730OC
    OpenUrlCrossRefPubMedWeb of Science
  37. ↵
    1. Liu T,
    2. Liu Y,
    3. Miller M, et al.
    Autophagy plays a role in FSTL1-induced epithelial mesenchymal transition and airway remodeling in asthma. Am J Physiol Lung Cell Mol Physiol 2017; 313: L27–L40. doi:10.1152/ajplung.00510.2016
    OpenUrlCrossRefPubMed
  38. ↵
    1. Forno E,
    2. Zhang R,
    3. Jiang Y, et al.
    Transcriptome-wide and differential expression network analyses of childhood asthma in nasal epithelium. J Allergy Clin Immunol 2020; 146: 671–675. doi:10.1016/j.jaci.2020.02.005
    OpenUrl
  39. ↵
    1. Shungin D,
    2. Winkler TW,
    3. Croteau-Chonka DC, et al.
    New genetic loci link adipose and insulin biology to body fat distribution. Nature 2015; 518: 187–196. doi:10.1038/nature14132
    OpenUrlCrossRefPubMedWeb of Science
  40. ↵
    1. Winkler TW,
    2. Justice AE,
    3. Graff M, et al.
    The influence of age and sex on genetic associations with adult body size and shape: a large-scale genome-wide interaction study. PLoS Genet 2015; 11: e1005378. doi:10.1371/journal.pgen.1005378
    OpenUrlCrossRefPubMed
  41. ↵
    1. GTEx Consortium
    . The Genotype-Tissue Expression (GTEx) project. Nat Genet 2013; 45: 580–585. doi:10.1038/ng.2653
    OpenUrlCrossRefPubMed
  42. ↵
    1. Suzuki T,
    2. Elias BC,
    3. Seth A, et al.
    PKCη regulates occludin phosphorylation and epithelial tight junction integrity. Proc Natl Acad Sci USA 2009; 106: 61–66. doi:10.1073/pnas.0802741106
    OpenUrlAbstract/FREE Full Text
  43. ↵
    1. Bisgaard H,
    2. Bonnelykke K,
    3. Sleiman PM, et al.
    Chromosome 17q21 gene variants are associated with asthma and exacerbations but not atopy in early childhood. Am J Respir Crit Care Med 2009; 179: 179–185. doi:10.1164/rccm.200809-1436OC
    OpenUrlCrossRefPubMedWeb of Science
  44. ↵
    1. Farzan N,
    2. Vijberger S,
    3. Hernandez-Pacheco N, et al.
    17q21 variant increases the risk of exacerbations in asthmatic children despite inhaled corticosteroid use. Allergy 2018; 73: 2083–2088. doi:10.1111/all.13499
    OpenUrl
    1. Hankinson JL,
    2. Odencrantz JR,
    3. Fedan KB
    Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159: 179–187. doi:10.1164/ajrccm.159.1.9712108
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top
View this article with LENS
Vol 57 Issue 4 Table of Contents
European Respiratory Journal: 57 (4)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A genome-wide association study of severe asthma exacerbations in Latino children and adolescents
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
A genome-wide association study of severe asthma exacerbations in Latino children and adolescents
Qi Yan, Erick Forno, Esther Herrera-Luis, Maria Pino-Yanes, Cancan Qi, Raimon Rios, Yueh-Ying Han, Soyeon Kim, Sam Oh, Edna Acosta-Pérez, Rong Zhang, Donglei Hu, Celeste Eng, Scott Huntsman, Lydiana Avila, Nadia Boutaoui, Michelle M. Cloutier, Manuel E. Soto-Quiros, Cheng-Jian Xu, Scott T. Weiss, Jessica Lasky-Su, Megan R. Kiedrowski, Camila Figueiredo, Jennifer Bomberger, Mauricio L. Barreto, Glorisa Canino, Wei Chen, Gerard H. Koppelman, Esteban G. Burchard, Juan C. Celedón
European Respiratory Journal Apr 2021, 57 (4) 2002693; DOI: 10.1183/13993003.02693-2020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
A genome-wide association study of severe asthma exacerbations in Latino children and adolescents
Qi Yan, Erick Forno, Esther Herrera-Luis, Maria Pino-Yanes, Cancan Qi, Raimon Rios, Yueh-Ying Han, Soyeon Kim, Sam Oh, Edna Acosta-Pérez, Rong Zhang, Donglei Hu, Celeste Eng, Scott Huntsman, Lydiana Avila, Nadia Boutaoui, Michelle M. Cloutier, Manuel E. Soto-Quiros, Cheng-Jian Xu, Scott T. Weiss, Jessica Lasky-Su, Megan R. Kiedrowski, Camila Figueiredo, Jennifer Bomberger, Mauricio L. Barreto, Glorisa Canino, Wei Chen, Gerard H. Koppelman, Esteban G. Burchard, Juan C. Celedón
European Respiratory Journal Apr 2021, 57 (4) 2002693; DOI: 10.1183/13993003.02693-2020
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Abstract
    • Introduction
    • Methods
    • Results
    • Discussion
    • Supplementary material
    • Shareable PDF
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Asthma and allergy
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Original Articles

  • Identifying early PAH biomarkers in systemic sclerosis
  • Viable virus aerosol propagation by PAP circuit leak
  • Ambulatory management of secondary spontaneous pneumothorax
Show more Original Articles

Asthma

  • Zinc finger protein 33B and atopy-related markers in asthma
  • Green and blue spaces and lung function in the Generation XXI cohort
  • Adrenal function recovery after durable OCS sparing with benralizumab
Show more Asthma

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society